Back to Browse Journals » Blood and Lymphatic Cancer: Targets and Therapy

Blood and Lymphatic Cancer: Targets and Therapy


Journal Articles:

- 56 records -

Clinical potential of midostaurin in advanced systemic mastocytosis

Chandesris MO, Damaj G, Lortholary O, Hermine O

Blood and Lymphatic Cancer: Targets and Therapy 2017, 7:25-35

Published Date: 3 May 2017

Uptake of lymphoma-derived exosomes by peripheral blood leukocytes

Ferguson Bennit HR, Gonda A, Oppegard LJ, Chi DP, Khan S, Wall NR

Blood and Lymphatic Cancer: Targets and Therapy 2017, 7:9-23

Published Date: 28 February 2017

MYC as therapeutic target in leukemia and lymphoma

Cortiguera MG, Batlle-LΓ³pez A, Albajar M, Delgado MD, LeΓ³n J

Blood and Lymphatic Cancer: Targets and Therapy 2015, 5:75-91

Published Date: 22 July 2015

IL-15 as a potential target in leukemia

Xiong Y, Bensoussan D, Decot V

Blood and Lymphatic Cancer: Targets and Therapy 2015, 5:55-63

Published Date: 9 April 2015

Targeting CD20 in chronic lymphocytic leukemia

Nahas MR, Arnason JE

Blood and Lymphatic Cancer: Targets and Therapy 2015, 5:43-53

Published Date: 10 March 2015

Emerging role of SOX11 in mantle cell lymphoma

Kuci V, NordstrΓΆm L, Jerkeman M, Ek S

Blood and Lymphatic Cancer: Targets and Therapy 2015, 5:35-42

Published Date: 27 February 2015

MicroRNAs as B-cell lymphoma biomarkers

Manterola L, Fernandez-Mercado M, Larrea E, Goicoechea I, Arestin M, Armesto M, Hernandez L, Lawrie CH

Blood and Lymphatic Cancer: Targets and Therapy 2015, 5:25-34

Published Date: 4 February 2015

Multiple myeloma: optimal management and long-term disease control

Sriskandarajah P, Davies FE

Blood and Lymphatic Cancer: Targets and Therapy 2014, 4:121-134

Published Date: 6 November 2014

Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources

Moormann AM, Skiles JL, Otieno JA, Buckle GC, Vik TA

Blood and Lymphatic Cancer: Targets and Therapy 2014, 4:91-99

Published Date: 23 September 2014

Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase

Farina F, Stasia A, Gambacorti-Passerini C

Blood and Lymphatic Cancer: Targets and Therapy 2014, 4:69-79

Published Date: 21 August 2014

Emerging targets in human lymphoma: targeting the MYD88 mutation

Wang JQ, Jeelall YS, Horikawa K

Blood and Lymphatic Cancer: Targets and Therapy 2013, 3:53-61

Published Date: 13 August 2013

Ruxolitinib as an emerging treatment in myelofibrosis

Emanuel RM, Geyer HL, Mesa RA

Blood and Lymphatic Cancer: Targets and Therapy 2013, 3:11-18

Published Date: 9 March 2013

Therapeutic developments in acute lymphoblastic leukemia

MacKenzie A, Kasner M

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:145-158

Published Date: 27 November 2012

Recent developments in myelofibrosis

Tibes R, Bogenberger JM, Mesa RA

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:125-136

Published Date: 2 July 2012

Advances in the diagnosis and management of lymphoma

Word ZH, Matasar MJ

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:29-55

Published Date: 3 February 2012

The evaluation and optimal use of rituximab in lymphoid malignancies

Robak T, Robak P, Smolewski P

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:1-16

Published Date: 4 January 2012

Reduced intensity treatment in early-stage Hodgkin’s lymphoma

Prodduturi P, Armitage JO

Blood and Lymphatic Cancer: Targets and Therapy 2011, 1:23-31

Published Date: 25 November 2011

mTOR inhibitor in the treatment of Hodgkin’s lymphoma: a case report

Ibeas P, Cantos B, Provencio M.

Blood and Lymphatic Cancer: Targets and Therapy 2011, 1:19-22

Published Date: 8 November 2011

Mantle cell leukemia as a cause of leukostasis

Smith D, Cable C, Chisholm C, Linz W, Koss W, Dobin S, Rappaport E

Blood and Lymphatic Cancer: Targets and Therapy 2011, 1:5-8

Published Date: 28 April 2011